Teva Pharmaceutical Industries (TEVA) Net Margin Growth (3y) (2012 - 2026)
Teva Pharmaceutical Industries (TEVA) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -3,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 948.00 |
| Mar 31, 2026 | 1,620.00 |
| Dec 31, 2025 | 4,432.00 |
| Sep 30, 2025 | 786.00 |
| Jun 30, 2025 | 1,407.00 |
| Mar 31, 2025 | 3,223.00 |
| Dec 31, 2024 | -580.00 |
| Sep 30, 2024 | -1,694.00 |
| Jun 30, 2024 | -2,641.00 |
| Mar 31, 2024 | 1,153.00 |
| Dec 31, 2023 | -4,366.00 |
| Sep 30, 2023 | 11,130.00 |
| Jun 30, 2023 | -2,701.00 |
| Mar 31, 2023 | -849.00 |
| Dec 31, 2022 | -3,681.00 |
| Sep 30, 2022 | 945.00 |
| Jun 30, 2022 | 915.00 |
| Mar 31, 2022 | -2,405.00 |
| Dec 31, 2021 | 6,285.00 |
| Sep 30, 2021 | 1,410.00 |